| Literature DB >> 10070845 |
J Lekakis1, M Mavrikakis, V Prassopoulos, S Gerali, N Sifakis, P Kostamis, S Stamatelopoulos.
Abstract
In-antimyosin scintigraphy offers a valuable noninvasive method for early detection of clinically silent cardiac involvement in patients with systemic sclerosis, even in the absence of left ventricular dysfunction. In these patients with positive antimyosin study results, intense pharmacologic treatment with vasodilators may be warranted.Entities:
Mesh：
Substances：
Year: 1999 PMID： 10070845 DOI： 10.1016/s1071-3581(99)90069-7
Source DB: PubMed Journal: J Nucl Cardiol ISSN： 1071-3581 Impact factor: 5.952